These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33652465)

  • 21. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease.
    Minnerop M; Weber B; Schoene-Bake JC; Roeske S; Mirbach S; Anspach C; Schneider-Gold C; Betz RC; Helmstaedter C; Tittgemeyer M; Klockgether T; Kornblum C
    Brain; 2011 Dec; 134(Pt 12):3530-46. PubMed ID: 22131273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study.
    Labayru G; Aliri J; Zulaica M; López de Munain A; Sistiaga A
    J Neuropsychol; 2020 Mar; 14(1):121-134. PubMed ID: 31407859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive, neuropsychological and emotional-behavioural functioning in a sample of children with myotonic dystrophy type 1.
    Ricci FS; Vacchetti M; Brusa C; D'Alessandro R; La Rosa P; Martone G; Davico C; Vitiello B; Mongini TE
    Eur J Paediatr Neurol; 2022 Jul; 39():59-64. PubMed ID: 35679764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
    Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
    Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive phenotype of childhood myotonic dystrophy type 1: A multicenter pooled analysis.
    Sweere DJJ; Moelands SVL; Klinkenberg S; Leenen L; Hendriksen JGM; Braakman HMH
    Muscle Nerve; 2023 Jul; 68(1):57-64. PubMed ID: 37129457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life in patients with myotonic dystrophy type 2.
    Rakocevic Stojanovic V; Peric S; Paunic T; Pesovic J; Vujnic M; Peric M; Nikolic A; Lavrnic D; Savic Pavicevic D
    J Neurol Sci; 2016 Jun; 365():158-61. PubMed ID: 27206898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cognitive profile of myotonic dystrophy type 1: A systematic review and meta-analysis.
    Okkersen K; Buskes M; Groenewoud J; Kessels RPC; Knoop H; van Engelen B; Raaphorst J
    Cortex; 2017 Oct; 95():143-155. PubMed ID: 28892766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain 1H magnetic resonance spectroscopic differences in myotonic dystrophy type 2 and type 1.
    Vielhaber S; Jakubiczka S; Gaul C; Schoenfeld MA; Debska-Vielhaber G; Zierz S; Heinze HJ; Niessen HG; Kaufmann J
    Muscle Nerve; 2006 Aug; 34(2):145-52. PubMed ID: 16642499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2.
    Krieger B; Schneider-Gold C; Genç E; Güntürkün O; Prehn C; Bellenberg B; Lukas C
    J Neurol; 2024 Jun; ():. PubMed ID: 38896263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Speech and language abnormalities in myotonic dystrophy: An overview.
    Hanoun S; Sun Y; Ebrahimi F; Ghasemi M
    J Clin Neurosci; 2022 Feb; 96():212-220. PubMed ID: 34789418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing cognitive-motor impairments in patients with myotonic dystrophy type 1.
    Filli L; Schwegler S; Meyer C; Killeen T; Easthope CS; Broicher SD; Curt A; Zörner B; Bolliger M; Jung HH; Petersen JA
    Neuromuscul Disord; 2020 Jun; 30(6):510-520. PubMed ID: 32527589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural white matter networks in myotonic dystrophy type 1.
    van Dorst M; Okkersen K; Kessels RPC; Meijer FJA; Monckton DG; van Engelen BGM; Tuladhar AM; Raaphorst J;
    Neuroimage Clin; 2019; 21():101615. PubMed ID: 30522973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal Changes in Neuropsychological Functioning in Japanese Patients with Myotonic Dystrophy Type 1: A Five Year Follow-Up Study.
    Fujino H; Suwazono S; Ueda Y; Kobayashi M; Nakayama T; Imura O; Matsumura T; Takahashi MP
    J Neuromuscul Dis; 2023; 10(6):1083-1092. PubMed ID: 37599536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Educational and Professional Qualifications of Adults With Myotonic Dystrophies - A Misleading Perception by the Myopathic Face?].
    Stahl K; Wenninger S; Schüller A; Montagnese F; Schoser B
    Fortschr Neurol Psychiatr; 2016 Apr; 84(4):211-6. PubMed ID: 27100845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning.
    Antonini G; Soscia F; Giubilei F; De Carolis A; Gragnani F; Morino S; Ruberto A; Tatarelli R
    J Rehabil Med; 2006 May; 38(3):181-5. PubMed ID: 16702085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2.
    Timchenko L
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of emotions conveyed by facial expression and body postures in myotonic dystrophy (DM).
    Lenzoni S; Bozzoni V; Burgio F; de Gelder B; Wennberg A; Botta A; Pegoraro E; Semenza C
    Cortex; 2020 Jun; 127():58-66. PubMed ID: 32169676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
    Suominen T; Bachinski LL; Auvinen S; Hackman P; Baggerly KA; Angelini C; Peltonen L; Krahe R; Udd B
    Eur J Hum Genet; 2011 Jul; 19(7):776-82. PubMed ID: 21364698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.